• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Ezaier Y, Hader A, Latif A, Khan ME, Ali W, Ali SK, Bashiri AH, Zakri W, Yusuf M, Rajamohan N, Ibrahim H. Solving the fouling mechanisms in composite membranes for water purification: An advance approach. Environ Res 2024;250:118487. [PMID: 38365055 DOI: 10.1016/j.envres.2024.118487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 01/17/2024] [Accepted: 02/13/2024] [Indexed: 02/18/2024]
2
Haen E, Köstlbacher A, Bader W, Greiner C, Hader A, Köber R, Wenzel-Seifert K, Wittmann M, Dörfelt A, Melchner D, Outlaw E, Brandl R. The dose-related reference range – a new tool for therapeutic drug monitoring (TDM). Pharmacopsychiatry 2011. [DOI: 10.1055/s-0031-1292489] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
3
Wittmann M, Köstlbacher A, Hader A, Köber R, Haen E. The impact of metabolic pathways to drug-drug interactions. Pharmacopsychiatry 2011. [DOI: 10.1055/s-0031-1292563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
4
Hader A, Beck S, Jahner T, Melchner D, Haen E. Identification of a slow CYP3A4 metabolizer by TDM – a case report. Pharmacopsychiatry 2011. [DOI: 10.1055/s-0031-1292305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
5
Hader A, Haen E. In what way dose-related and therapeutic reference ranges are different and what is the use of them? Pharmacopsychiatry 2009. [DOI: 10.1055/s-0029-1240123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
6
Hader A, Kirchheiner J, Melchner D, Loehr A, Haen E. Validation of PCR-Methods in a TDM-Laboratory. Pharmacopsychiatry 2008. [DOI: 10.1055/s-0028-1088250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
7
Hader A, Kirchheiner J, Jahner T, Haen E. Therapeutic Drug Monitoring in Psychiatry – Genotyping amends clinical pharmacological comments. Pharmacopsychiatry 2007. [DOI: 10.1055/s-2007-991861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA